Medical devices, healthcare technology and the business of care
510(k) clearance · K260080

Pro-Line XL Power Injectable Central Venous Catheter and Pro-Line XL Tunneler

Medical Components, Inc. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK260080

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-10-09 for K260080, submitted by Medical Components, Inc. (Medcomp) of Harleysville, Pennsylvania. The filing covers the Pro-Line XL Power Injectable Central Venous Catheter and the Pro-Line XL Tunneler, classified under product code LJS within regulation 880.5970, the long-term (greater than 30 days) intravascular therapeutic catheter category, with a General Hospital review panel. The application was received 01/12/2026 as a traditional 510(k) and was not reviewed by a third party.

SESE means the submission was cleared as substantially equivalent to a legally marketed predicate device; it is not a PMA approval. The public record does not identify the predicate device, the specific modifications or components assessed, or the basis for the equivalence determination, and no summary statement is included in the available material. Whether the catheter and tunneler were reviewed as a system or separately is also not stated. The page was last updated 10/19/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Oct 9, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260080
Regulatory pathway
510(k) premarket notification
Product code
LJS
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days.

Product code
LJS
FDA device class
2

FDA decision timeline

  1. K260080 received

    Application receipt date recorded by FDA.

  2. K260080 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medical Components, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Harleysville, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records